Company:  ABBVIE INC. (ABBV)
Form Type:  4
Filing Date:  11/8/2019 
CIK:  0001551152 
Address:  1 NORTH WAUKEGAN ROAD 
City, State, Zip:  NORTH CHICAGO, Illinois 60064 
Telephone:  (847) 932-7900 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$87.98  
Change: 
-1.04 (-1.17%)  
Trade Time: 
10:33 AM EST  
Market Cap: 
$130.11B
Trade ABBV now with 

© 2019  
Description of Business
AbbVie(1) is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. AbbVie also has a pipeline of promising new medicines in clinical development across such important medical specialties as immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. AbbVie was incorporated in Delaware on April 10, 2012.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    REPORTING OWNERS
    SIGNATURES